Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.

AUTOR(ES)

Murray, H W

RESUMO

In experimental visceral leishmaniasis, euthymic but not athymic (nude) BALB/c mice respond to conventional treatment with pentavalent antimony, indicating that the in vivo efficacy of antimony is T cell dependent. This finding correlates with frequent antimony treatment failures for T-cell-deficient patients with visceral leishmaniasis. To determine whether the in vivo efficacies of alternative antileishmanial agents also require T cells, Leishmania donovani-infected euthymic and nude BALB/c mice were treated with pentamidine or amphotericin B. Pentamidine induced leishmanistatic activity in euthymic mice but had little effect in nude mice. In contrast, amphotericin B exerted potent leishmanicidal activities in both euthymic and nude animals. These results suggest that amphotericin B may be of particular use for T-cell-deficient patients with visceral leishmaniasis.

Documentos Relacionados

• Suppression of Posttreatment Recurrence of Experimental Visceral Leishmaniasis in T-Cell-Deficient Mice by Oral Miltefosine
• T-cell-deficient mice display normal recovery from experimental rotavirus infection.
• Massive Apoptosis of Thymocytes in T-Cell-Deficient Id1 Transgenic Mice
• Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres
• Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis